Applied Therapeutics Announces Positive Results from 12-mont

Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite Sustained, statistically significant reduction in sorbitol in...

Related Keywords

Maeve Conneighton , Advanz Pharma , Exchange Commission , Therapeutics Inc , Drug Administration , European Medicines Agency , Health Index , Twitter , Nasdaq , Sorbitol Dehydrogenase , Aldose Reductase Inhibitor , New Drug Application , Analysis Results , Conference Call , Applied Therapeutics , Events Page , Investor Relations , Applied Therapeutic , Dehydrogenase Deficiency , Aldose Reductase , Orphan Medicinal Product Designation , Orphan Drug Designation , Pediatric Rare Disease , Fast Track , Diabetic Cardiomyopathy , Private Securities Litigation Reform Act , Markets ,